Clinical trial NCT03590197 - References

Generalized Epilepsy — Effect of Melatonin on Seizure Outcome, Neuronal Damage and Quality of Life in Patients With Generalized Epilepsy

Citation(s)

•   Aguiar CC, Almeida AB, Araújo PV, Vasconcelos GS, Chaves EM, do Vale OC, Macêdo DS, de Sousa FC, Viana GS, Vasconcelos SM
  Anticonvulsant effects of agomelatine in mice. Epilepsy Behav. 2012 Jul;24(3):324-8. doi: 10.1016/j.yebeh.2012.04.134. Epub 2012 Jun
•   AlAhmed S, Herbert J
  Effect of agomelatine and its interaction with the daily corticosterone rhythm on progenitor cell proliferation in the dentate gyrus of the adult rat. Neuropharmacology. 2010 Nov;59(6):375-9. doi: 10.1016/j.neuropharm.2010.05.008. Ep
•   Amudhan S, Gururaj G, Satishchandra P
  Epilepsy in India I: Epidemiology and public health. Ann Indian Acad Neurol. 2015 Jul-Sep;18(3):263-77. doi: 10.4103/0972-2327.160093. Review.
•   Bertaina-Anglade V, Drieu-La-Rochelle C, Mocaër E, Seguin L
  Memory facilitating effects of agomelatine in the novel object recognition memory paradigm in the rat. Pharmacol Biochem Behav. 2011 Jun;98(4):511-7. doi: 10.1016/j.pbb.2011.02.015. Epub 2011 Fe
•   Borowicz KK, Kaminski R, Gasior M, Kleinrok Z, Czuczwar SJ
  Influence of melatonin upon the protective action of conventional anti-epileptic drugs against maximal electroshock in mice. Eur Neuropsychopharmacol. 1999 Mar;9(3):185-90.
•   Bourin M, Mocaër E, Porsolt R
  Antidepressant-like activity of S 20098 (agomelatine) in the forced swimming test in rodents: involvement of melatonin and serotonin receptors. J Psychiatry Neurosci. 2004 Mar;29(2):126-33.
•   Brigo F, Igwe SC, Del Felice A
  Melatonin as add-on treatment for epilepsy. Cochrane Database Syst Rev. 2016 Aug 11;(8):CD006967. doi: 10.1002/14651858.CD006967.pub4. Review.
•   Buysse DJ, Reynolds CF 3rd, Monk TH, Hoch CC, Yeager AL, Kupfer DJ
  Quantification of subjective sleep quality in healthy elderly men and women using the Pittsburgh Sleep Quality Index (PSQI). Sleep. 1991 Aug;14(4):331-8. Erratum in: Sleep 1992 Feb;15(1):
•   Cockerell OC, Sander JW, Shorvon SD
  Remission of epilepsy. The NGPS. National General Practice Study of Epilepsy. Lancet. 1995 Nov 4;346(8984):1228.
•   Costa-Lotufo LV, Fonteles MM, Lima IS, de Oliveira AA, Nascimento VS, de Bruin VM, Viana GS
  Attenuating effects of melatonin on pilocarpine-induced seizures in rats. Comp Biochem Physiol C Toxicol Pharmacol. 2002 Apr;131(4):521-9.
•   Cramer JA, Perrine K, Devinsky O, Bryant-Comstock L, Meador K, Hermann B
  Development and cross-cultural translations of a 31-item quality of life in epilepsy inventory. Epilepsia. 1998 Jan;39(1):81-8.
•   Fenoglio-Simeone K, Mazarati A, Sefidvash-Hockley S, Shin D, Wilke J, Milligan H, Sankar R, Rho JM, Maganti R
  Anticonvulsant effects of the selective melatonin receptor agonist ramelteon. Epilepsy Behav. 2009 Sep;16(1):52-7. doi: 10.1016/j.yebeh.2009.07.
•   Fisher RS, Cross JH, D'Souza C, French JA, Haut SR, Higurashi N, Hirsch E, Jansen FE, Lagae L, Moshé SL, Peltola J, Roulet Perez E, Scheffer IE, Schulze-Bonhage A, Somerville E, Sperling M, Yacubian EM, Zuberi SM
  Instruction manual for the ILAE 2017 oper
•   Goldberg-Stern H, Oren H, Peled N, Garty BZ
  Effect of melatonin on seizure frequency in intractable epilepsy: a pilot study. J Child Neurol. 2012 Dec;27(12):1524-8. doi: 10.1177/0883073811435916. Epub 2012 Feb 28.
•   Gupta M, Aneja S, Kohli K
  Add-on melatonin improves quality of life in epileptic children on valproate monotherapy: a randomized, double-blind, placebo-controlled trial. Epilepsy Behav. 2004 Jun;5(3):316-21.
•   Gupta M, Aneja S, Kohli K
  Add-on melatonin improves sleep behavior in children with epilepsy: randomized, double-blind, placebo-controlled trial. J Child Neurol. 2005 Feb;20(2):112-5.
•   Gupta M, Gupta YK, Agarwal S, Aneja S, Kohli K
  A randomized, double-blind, placebo controlled trial of melatonin add-on therapy in epileptic children on valproate monotherapy: effect on glutathione peroxidase and glutathione reductase enzymes. Br J Clin
•   Lerche H, Daniluk J, Lotay N, DeRossett S, Edwards S, Brandt C
  Efficacy and safety of ezogabine/retigabine as adjunctive therapy to specified single antiepileptic medications in an open-label study of adults with partial-onset seizures. Seizure. 2015 Aug
•   Lima E, Cabral FR, Cavalheiro EA, Naffah-Mazzacoratti Mda G, Amado D
  Melatonin administration after pilocarpine-induced status epilepticus: a new way to prevent or attenuate postlesion epilepsy? Epilepsy Behav. 2011 Apr;20(4):607-12. doi: 10.1016/j.yebeh
•   Liu J, Clough SJ, Hutchinson AJ, Adamah-Biassi EB, Popovska-Gorevski M, Dubocovich ML
  MT1 and MT2 Melatonin Receptors: A Therapeutic Perspective. Annu Rev Pharmacol Toxicol. 2016;56:361-83. doi: 10.1146/annurev-pharmtox-010814-124742. Epub 2015 Oct 23. R
•   Lopes MC, Quera-Salva MA, Guilleminault C
  Non-REM sleep instability in patients with major depressive disorder: subjective improvement and improvement of non-REM sleep instability with treatment (Agomelatine). Sleep Med. 2007 Dec;9(1):33-41. Epub 2007 Se
•   Ma Y, Sun X, Li J, Jia R, Yuan F, Wei D, Jiang W
  Melatonin Alleviates the Epilepsy-Associated Impairments in Hippocampal LTP and Spatial Learning Through Rescue of Surface GluR2 Expression at Hippocampal CA1 Synapses. Neurochem Res. 2017 May;42(5):1438-1
•   MacDonald BK, Johnson AL, Goodridge DM, Cockerell OC, Sander JW, Shorvon SD
  Factors predicting prognosis of epilepsy after presentation with seizures. Ann Neurol. 2000 Dec;48(6):833-41. Erratum in: Ann Neurol 2001 Apr;49(4):547. Ann Neurol 2001 Dec;50(6)
•   Mevissen M, Ebert U
  Anticonvulsant effects of melatonin in amygdala-kindled rats. Neurosci Lett. 1998 Nov 20;257(1):13-6.
•   O'Donoghue MF, Duncan JS, Sander JW
  The National Hospital Seizure Severity Scale: a further development of the Chalfont Seizure Severity Scale. Epilepsia. 1996 Jun;37(6):563-71.
•   Rocha AKAA, de Lima E, Amaral F, Peres R, Cipolla-Neto J, Amado D
  Altered MT1 and MT2 melatonin receptors expression in the hippocampus of pilocarpine-induced epileptic rats. Epilepsy Behav. 2017 Jun;71(Pt A):23-34. doi: 10.1016/j.yebeh.2017.01.020. Epub
•   Sanchez-Barcelo EJ, Rueda N, Mediavilla MD, Martinez-Cue C, Reiter RJ
  Clinical Uses of Melatonin in Neurological Diseases and Mental and Behavioural Disorders. Curr Med Chem. 2017 Nov 20;24(35):3851-3878. doi: 10.2174/0929867324666170718105557. Review.
•   Singer MA
  Effects of furosemide and ethacrynic acid on cation transport across phospholipid bilayer membranes. Can J Physiol Pharmacol. 1974 Oct;52(5):930-41.
•   Tchekalarova J, Petkova Z, Pechlivanova D, Moyanova S, Kortenska L, Mitreva R, Lozanov V, Atanasova D, Lazarov N, Stoynev A
  Prophylactic treatment with melatonin after status epilepticus: effects on epileptogenesis, neuronal damage, and behavioral change
•   Vimala PV, Bhutada PS, Patel FR
  Therapeutic potential of agomelatine in epilepsy and epileptic complications. Med Hypotheses. 2014 Jan;82(1):105-10. doi: 10.1016/j.mehy.2013.11.017. Epub 2013 Nov 21.
•   Yahyavi-Firouz-Abadi N, Tahsili-Fahadan P, Riazi K, Ghahremani MH, Dehpour AR
  Involvement of nitric oxide pathway in the acute anticonvulsant effect of melatonin in mice. Epilepsy Res. 2006 Feb;68(2):103-13. Epub 2006 Jan 10.
•   Yalýn O, Arman F, Erdogan F, Kula M
  A comparison of the circadian rhythms and the levels of melatonin in patients with diurnal and nocturnal complex partial seizures. Epilepsy Behav. 2006 May;8(3):542-6. Epub 2006 Mar 9.

Effect of Melatonin on Seizure Outcome, Neuronal Damage and Quality of Life in Patients With Generalized Epilepsy: A Randomized, add-on Placebo-controlled Clinical Trial

Details for clinical trial NCT03590197